Home
Targos Molecular Pathology

Targos Molecular Pathology Market Share Analysis for July 2026

Our mission is to restore hope by speeding the development of innovative diagnostics and effective treatments to improve care.

Industry: N/A

Domaintargos-gmbh.de

Year Founded2005

Employees51 - 200

Annual Revenue$2M - $5M

Targos Molecular Pathology

Targos Molecular Pathology (including company regionals)

targos-gmbh.de

See more website traffic and engagement information

Targos Molecular Pathology Revenue up to July 2026 is 2M - 5M

revenue generated by Targos Molecular Pathology top domains

Targos Molecular Pathology top domains revenue over 3 years

Revenue for Targos Molecular Pathology top domains

targos-gmbh.de2M - 5M

See more with Sales Intelligence

Total visits to Targos Molecular Pathology's top domains

Understand Targos Molecular Pathology market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Targos Molecular Pathology's top domains

Analyze Targos Molecular Pathology engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Targos Molecular Pathology's top domains

See how Targos Molecular Pathology keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Targos Molecular Pathology top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Targos Molecular Pathology

These are the website technologies, by industry, used by Targos Molecular Pathology top domains

Content Management System (3)

WordPress

Widget (3)

Twemoji

Audio Video Media (2)

YouTube

Conversion & Analytics (2)

Matomo (Previously Piwik)

More Technologies

7

See all

News & Signals from Targos Molecular Pathology

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDiscoverylifesciences acquired Targos Gmbh on May 18th '21.Discovery Life Sciences said on Tuesday that it has acquired German biomarker development services firm Targos Molecular Pathology.

NewsTargos Gmbh is developing L1CAM-specific liquid.The consortium partners iCellate (Solna, Sweden) and Targos GmbH (Kassel, Germany), will develop L1CAM-specific liquid (blood-based) and solid (tumor-based) biopsy methods, respectively.